Nicotine Gum Market Size, Share and Growth Forecast for 2024 - 2031

Nicotine Gum Market by Product (Upper Arm Blood Pressure Monitor, Finger Blood Pressure Monitor, Wrist Blood Pressure Monitor), Technology (Wi-Fi Based, Bluetooth Based), End User (Hospital, Clinic, Home Care Setting, Others), and Region for 2024-2031

Industry: Food and Beverages

Published Date: August-2024

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 137

Report ID: PMRREP34733

Report Price

$ 4900*

Buy Now

Nicotine Gum Market Size, Share, & Growth Analysis

The global nicotine gum market is estimated to value at US$2 .71 Bn by the end of 2031 from US$1.68 Bn recorded in 2024. The market is expected to secure a CAGR of 7.1 % during the forecast period from 2024 to 2031.

Key Highlights of the Market

  • Increasing number of smokers fuels market demand.
  • The market is projected to expand due to increasing smoking cessation efforts.
  • Partnerships with healthcare providers can boost market penetration.
  • Pharmacies segment currently holds the largest market share.
  • Type 2mg nicotine gum to exhibit a CAGR of 5.7% through 2031.
  • Asia Pacific to record a CAGR of 6.2% through 2031.

Market Attributes

Key Insights

Market Size (2024E)

US$1.68 Bn

Projected Market Value (2031F)

US$2.71 Bn

Global Market Growth Rate (CAGR 2024 to 2031)

7.1 %

Historical Market Growth Rate (CAGR 2019 to 2023)

5.3 %

nicotine gum market size and growth rate, 2024 - 2031, US$ bn

Market Introduction and Trend Analysis

The nicotine gum market is an integral segment of the smoking cessation aids industry, addressing the global challenge of nicotine addiction. Nicotine gum offers a convenient, over-the-counter solution for individuals seeking to quit smoking by providing a controlled dose of nicotine to reduce withdrawal symptoms and cravings.

The market has experienced significant growth due to rising health awareness, supportive government initiatives, and increasing adoption of smoking cessation programs. Innovations in product formulations, such as new flavors and enhanced nicotine delivery systems, have further propelled market expansion.

Shift toward e-commerce and online pharmacies has broadened product accessibility, making nicotine gum a popular choice among consumers aiming to quit smoking. The market includes the development of advanced formulations with enhanced nicotine delivery and new flavors to improve user experience.

Personalized nicotine gums tailored to individual needs are gaining traction, along with increased use of digital health tools for smoking cessation. Eco-friendly packaging and improvements in gum texture and taste also reflect consumer preferences.

The rise of e-commerce platforms is further expanding market reach and accessibility. Use of digital health resources to assist with quitting smoking initiatives.

Asia Pacific Nicotine Gum Market Grows Significantly

Region

CAGR through 2031

Asia Pacific

6.2 %

Asia Pacific region is expected to be the rapidly growing market for nicotine gum over the forecast period. This growth can be attributed to increasing demand for innovative smoking cessation products and heightened competition among major tobacco companies. The market in Japan is particularly dynamic, offering significant opportunities for expansion. Additionally, strict anti-smoking regulations in countries like India and China are driving the demand for nicotine replacement products, including gums.

Regulatory measures aim to reduce smoking rates, thereby encouraging smokers to switch to safer alternatives. As a result, the nicotine gum market in Asia Pacific is poised for rapid growth, supported by favorable regulatory environments and the growing awareness of the health benefits of quitting smoking.

nicotine gum market, by region, 2024 - 2031=

Type- 2 Mg Nicotine Gum to Exhibit 5.7% CAGR in the Market

Category

Projected CAGR through 2031

Type - 2 mg

5.7%

Light smokers who smoke fewer than 25 cigarettes per day benefit from the 2 mg category, which has a significant market share. Because 2 mg nicotine gums are easily accessible and come in a variety of tastes, potential customers are drawn to them, which seems to be allowing expansion to pick up speed during the projected period.

The effects of nicotine withdrawal are lessened and controlled using nicorette 2 mg gum. It is advised to support smokers who are reluctant or unable to give up, help those who try to quit or lower their chance of quitting, and to provide smokers and anyone around them with a reasonably safe alternative to smoking.

Pharmacies Segment to Top the Market

Category

Projected CAGR through 2031

Distribution Channel  – Pharmacies

6.8%

Pharmacies segment currently holds the largest market share in the market, primarily due to its ability to assure customers of the quality and authenticity of products. Pharmacies are trusted by consumers, as they provide professional advice and guidance from trained pharmacists and general practitioners. This trust fosters consumer loyalty and drives repeat purchases. Pharmacies segment is expected to record a CAGR of 6.8% through 2031.

As awareness of smoking cessation aids grows, pharmacies are expected to see significant increases in product sales and marketing efforts during the analysis period. Pharmacists and healthcare professionals play a crucial role in recommending appropriate nicotine replacement therapies, including nicotine gum, to smokers seeking to quit. This personalized guidance enhances the credibility of pharmacies and further strengthens their position as the leading distribution channel for nicotine gum products.

Historical Growth and Course Ahead

The nicotine gum market has seen notable growth driven by rising health awareness and effective smoking cessation initiatives. Key players like Pfizer and GlaxoSmithKline established dominance with successful products, while government support and public health campaigns encouraged quitting.

Innovations in gum formulations and flavors also contributed to market expansion, catering to diverse consumer preferences. The market is expected to continue growing, fueled by advancements in personalized nicotine gums and increased focus on health.

Future growth will be supported by ongoing research and development, strategic partnerships, and the rise of e-commerce, enhancing accessibility and consumer reach. Enhanced regulatory support and evolving consumer needs will drive sustained market momentum.

Market Growth Factors

Rising Number of Smokers Seeking Effective Alternatives

The rising number of smokers seeking effective alternatives is a significant growth driver for the nicotine gum market. As awareness of the health risks associated with smoking increases, many individuals are motivated to quit or reduce their tobacco use.

Many smokers are turning to nicotine gum as a viable cessation aid due to its proven effectiveness in alleviating withdrawal symptoms and managing cravings. This shift is further fueled by public health campaigns, workplace wellness programs, and societal pressure to adopt healthier lifestyles. Consequently, the demand for nicotine gum is rising, as smokers seek accessible and effective solutions to help them quit and improve their health.

Introduction of Flavored Gums Attracting Young Consumers

The introduction of flavored gums is significantly driving growth in the nkicotine gum market by attracting young consumers who prefer more appealing and enjoyable cessation aids. Traditional nicotine gums often had limited flavors, which could be a deterrent for younger users accustomed to variety and taste in their products.

By offering a range of flavors such as mint, fruit, and cinnamon, manufacturers are making nicotine gum more palatable and attractive to a younger demographic. This not only enhances user experience but also increases the likelihood of adherence to smoking cessation programs. As a result, flavored nicotine gums are expanding the market reach, tapping into a segment that values both efficacy and flavor diversity.

Factors Impeding the Market Growth

Competition from Alternative Nicotine Replacement Therapies

Competition from alternative nicotine replacement therapies (NRT), such as patches and lozenges, is a significant factor impeding the growth of the nicotine gum market. Patches offer a convenient, hands-free approach by delivering a steady dose of nicotine over an extended period, which can be appealing to users seeking a simpler solution.

Lozenges provide a discreet, flavorful option that can also aid in reducing cravings. These alternatives often appeal to different consumer preferences and may be perceived as more effective or easy to use than gum. Consequently, the presence of these competing NRT options diversifies consumer choices and can impact the market share and growth of nicotine gum products.

Side Effects Associated with Nicotine Gum Usage

Side effects associated with nicotine gum usage, such as mouth irritation and digestive issues, are notable factors impeding market growth. Users may experience discomfort, including sore gums, mouth ulcers, or throat irritation, which can deter consistent use.

Gastrointestinal problems like nausea or upset stomach can occur, further discouraging potential users. These adverse effects can impact user satisfaction and adherence to smoking cessation programs, leading to decreased demand for nicotine gum compared to other nicotine replacement therapies with fewer or less severe side effects.

Future Opportunities for the Nicotine Gum Companies

Increasing Awareness of Smoking Cessation Aids

Increasing awareness of smoking cessation aids is a major growth driver for the nicotine gum market. As public health campaigns and educational programs highlight the risks of smoking and the benefits of quitting, many individuals are turning to nicotine gum as a proven aid.

Enhanced understanding of cessation methods and the effectiveness of nicotine gum in reducing withdrawal symptoms and cravings encourage its adoption. This growing awareness supports wide acceptance and usage, fueling demand and driving market expansion as smokers seek effective solutions to overcome nicotine addiction.

Expansion in Renewable Energy Sector for Protective Coatings Applications

Rising health consciousness and a strong desire to quit smoking are significant growth drivers for the nicotine gum market. As people become increasingly aware of the health risks associated with smoking, such as lung cancer and heart disease, there is a growing push to adopt healthy lifestyles.

This heightened health awareness motivates smokers to seek effective cessation aids, with nicotine gum being a popular choice due to its proven effectiveness in managing cravings and withdrawal symptoms. Additionally, societal pressure and support for smoking cessation programs further drive individuals to use nicotine gum, boosting market demand and encouraging continued growth.

Competitive Landscape for the Nicotine Gum Market

The nicotine gum market's competitive landscape is characterized by a mix of large pharmaceutical companies and specialized manufacturers. Leading players like Pfizer Inc., GlaxoSmithKline plc, and Johnson & Johnson Services, Inc. dominate the market with established brands.

Innovation and product differentiation, such as new flavors and improved delivery mechanisms, are key competitive strategies. Small companies, like Fertin Pharma and Nicotek LLC focus on niche markets and contract manufacturing. The market is also witnessing increased competition from generic brands and online retailers, intensifying the need for strategic marketing and distribution partnerships.

Recent Development in the Nicotine Gum Market

August 2023

  • Starface, a Gen Z acne brand, founded "blip," a new business to market nicotine gum and lozenges. In addition to shipping its NRTs (nicotine replacement therapy) to clients online, Blip also distributes its products to a few CVS locations nationwide. The millennial demographic is the primary target market for the creative retro-packaged products.

Nicotine Gum Market Report Scope

Attributes

Details

Forecast Period

2024 to 2031

Historical Data Available for

2019 to 2023

Market Analysis

US$ Billion for Value

Key Regions Covered

  • North America
  • Europe
  • East Asia
  • South Asia & Pacific
  • The Middle East and Africa
  • Latin America

Key Market Segments Covered

  • By Type
  • By Application
  • By Distribution channel
  • Region

Key Companies Profiled in the Report

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Perrigo Company plc
  • Fertin Pharma A/S
  • Revolymer plc
  • Cipla Inc.
  • Novartis AG
  • ITC Limited
  • Takeda Pharmaceutical Company Limited
  • Cambrex Corporation
  • Sanofi S.A.
  • Dr. Reddy's Laboratories Ltd.
  • Alchem International Pvt. Ltd.
  • Nicotek LLC

Report Coverage

  • Market Forecast and Trends
  • Company Share Analysis
  • Competitive Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives  

Customization & Pricing

Available upon request

Nicotine Gum Market Segmentation

By Type

  • 2 mg
  • 4 mg
  • 6 mg

By Application

  • Smoking Cessation
  • Reduction of Smoking

By Distribution channel

  • Supermarkets
  • hypermarkets
  • Pharmacies
  • Online stores

By Region

  • North America
  • Europe
  • Asia-Pacific
  • The Middle East and Africa
  • Latin America

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Perrigo Company plc
  • Fertin Pharma A/S
  • Revolymer plc
  • Cipla Inc.
  • Novartis AG
  • ITC Limited
  • Takeda Pharmaceutical Company Limited
  • Cambrex Corporation
  • Sanofi S.A.
  • Dr. Reddy's Laboratories Ltd.
  • Alchem International Pvt. Ltd.
  • Nicotek LLC

Frequently Asked Questions

Surging demand for nicotine gum is driven by increased smoking cessation efforts, and improved nicotine delivery systems, making it a popular choice for quitting smoking.

The global nicotine gum market is estimated to value at US$2 .71 Bn by the end of 2031.

Some of the key players operating in the market are Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Perrigo Company plc and Fertin Pharma A/S

Pharmacies segment to record notable share of the market.

A compelling opportunity in the nicotine gum market is developing personalized, prescription-based nicotine gums tailored to individual needs.

Asia Pacific to account for the significant share in the market.

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate